Th17 Responses Evaluated in RA Patients on Inhibitors of TNFα
NCT02620189
·
clinicaltrials.gov ↗
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Rheumatoid Arthritis
Interventions
DRUG:
Anti-TNF Biologics Therapy
Sponsor
Queen Mary University of London